Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | EXEL Exelixis, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $57.22 -2.0% | $15.86 +5.3% |
| StockIQ Score | 69B- Moderate Risk: Medium | 38F Weak Risk: Medium |
| Technical | 82A- | 21F |
| Fundamental | 79B+ | 35F |
| Growth | 76B+ | 50C- |
| Fair Value | 50C- | 38F |
| News | 56C | 50C- |
| Quality | 58C | 50C- |
| Risk | 56C | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
EXEL outperforms AAPG in every metric, with an investor score of 71 versus 41 and a “STRONG” rating compared to AAPG’s “WEAK.” Its technical (87 vs 34), fundamental (79 vs 35), growth (76 vs 50) and valuation (50 vs 38) scores are all markedly higher, indicating stronger performance across these categories.